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Abstract
Background: Many analyses of gene expression data involve hypothesis tests of an interaction term between two
fixed effects, typically tested using a residual variance. In expression studies, the issue of variance heteroscedasticity
has received much attention, and previous work has focused on either between-gene or within-gene
heteroscedasticity. However, in a single experiment, heteroscedasticity may exist both within and between genes.
Here we develop flexible shrinkage error estimators considering both between-gene and within-gene
heteroscedasticity and use them to construct F-like test statistics for testing interactions, with cutoff values
obtained by permutation. These permutation tests are complicated, and several permutation tests are investigated
here.
Results: Our proposed test statistics are compared with other existing shrinkage-type test statistics through
extensive simulation studies and a real data example. The results show that the choice of permutation procedures
has dramatically more influence on detection power than the choice of F or F-like test statistics. When both types
of gene heteroscedasticity exist, our proposed test statistics can control preselected type-I errors and are more
powerful. Raw data permutation is not valid in this setting. Whether unrestricted or restricted residual permutation
should be used depends on the specific type of test statistic.
Conclusions: The F-like test statistic that uses the proposed flexible shrinkage error estimator considering both
types of gene heteroscedasticity and unrestricted residual permutation can provide a statistically valid and
powerful test. Therefore, we recommended that it should always applied in the analysis of real gene expression
data analysis to test an interaction term.
Background
The regulation of gene expression starts when a cell’s
DNA is transcribed into mRNA. The simultaneous
expression profiles of many genes under different cir-
cumstances can provide insight into physiological pro-
cesses. Using modern technologies in gene expression
e x p e r i m e n t ss u c ha so l i g o n ucleotide arrays [1], and
cDNA spotted arrays [2], many scientists have made
novel discoveries about complex biological processes of
yeast [3,4], drosophila [5], mice [6], humans [7], and
other species. Recently one such study also included
RNA-seq [8]. Statistical methodologies and issues
involved in microarray data analysis have been widely
reviewed [9-12], and it is expected that many of the
same issues will need to be addressed with RNA-seq.
The analysis of variance (ANOVA) model is a popular
statistical modeling method for the analysis of microar-
rays. Since its introduction by Kerr et al. [13], it has
been extensively examined for use in this setting
[14-21]. Kerr et al. constructed an ANOVA model that
included the gene effect as a fixed effect. This model
assumes identically and independently distributed resi-
dual errors across genes. The advantage of this model is
that the large number of genes involved in a microarray
experiment results in huge degrees of freedom for the
error estimate, which can lead to a very powerful test.
However, the common assumption of homoscedasticity
may not hold true in this setting [22]. One alternative is
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ing test statistics from gene-specific models may have
limited power because the biological sample size for
each gene in a microarray experiment is usually small.
To address this problem of limited power, researchers
have proposed other methods for obtaining more infor-
mation across genes, ranging from a simple equal-
weighted average of a gene-specific error estimate and
the global average of all gene-specific error estimates (F2
statistic proposed by Wu et al. [19] to empirical Baye-
sian modeling of all gene-specific errors [23-26]. Other
variations [27-29] used different variance modeling stra-
tegies to address the heteroscedasticity problem, but no
clear winner has emerged [30]. Huang and Liu [31]
extended the test statistics proposed by Cui et al.[ 2 8 ]
by assuming a normal distribution on the mean and
then deriving an empirical Bayes likelihood ratio test.
The resulting test statistic shrinks both the mean and
variances.
In addition to the problem of between-gene heterosce-
dasticity, we must also be concerned with within-gene
heteroscedasticity. For example, in the study of simple
differential gene expression between a treatment group
and a control group, the variance in the treatment arm
may differ from that in the control arm. Some
approaches to this problem include a general Bayesian
framework to model heteroscedastic error in a single
generalized linear mixed model setting [32] and a struc-
tural model placed on the error variances specific to
each gene and treatment combination [33].
As gene expression studies become more popular, the
complexity of the experiment increases. Instead of only
simple treatment and control experiments, two or more
factor experiments are being conducted. This increase
in experiment complexity has led to many scientific
questions involving the hypothesis testing of an interac-
tion between two factors. For example, testing a probe
by genotype interaction can result in inferences about
polymorphism in the probe, such as single nucleotide
polymorphism (SNP) and insertion-deletion (indel)
[34-37]; testing a probe by sex can imply that alternative
splicing occurs between male and female subjects [38];
and in pharmacogenomic studies, testing the genotype-
drug/treatment or genotype-disease interaction may be
of interest [39]. Thus far, all the development of
ANOVA methods for microarray studies has focused on
tests of main effects.
Here, a generalized shrinkage estimator incorporating
both within- and between-gene heteroscedasticities is
developed (see Lehmann and Cesella [40] for a review
of shrinkage estimation). In any given experiment, both
within-gene and between-gene heteroscedasticity may
exist; thus, taking these possibilities into account should
lead to an improved test statistic. Moreover, given the
increasing complexity of recent studies and the bur-
geoning interest in hypotheses that involve interactions,
we focus on an improved shrinkage-based F-test for
interaction terms.
Methods
Here we develop new shrinkage estimates for the error
term and show how to use these estimates to construct
F-like statistics. We then estimate the null distribution
of these statistics by using permutation tests.
Shrinkage error estimators
Shrinkage error estimators pull individual error esti-
mates toward shrinkage targets, with the amount of
shrinkage depending on the variability of individual
error estimates [28,40]. Let the gene-specific error esti-
mates for all genes i and subgroups k be
 
ˆ σ2
1,1,..., ˆ σ2
1,K,..., ˆ σ2
I,K
 
,
i = 1,...,I, k = 1,..., K, and let σ2
i,k be the true variance of
gene i in group k. When the experimental design is
balanced, ˆ σ2
i,k is the residual mean square for gene i in
group k and ν ˆ σ2
i,k/σ2
i,k ∼ χ2
ν,w h e r eν represents the
degrees of freedom for the error estimates.
The choices of shrinkage targets in microarray data
include the following:
1. Specific values for each gene-group combination
2. Gene-specific values that are the same across all
other groups
3. Group-specific values that are the same across
genes but different across groups
4. A single point representing the underlying com-
mon error
Correspondingly, these targets are correct when (1)
there are both within-gene and between-gene heterosce-
dasticity; (2) there is only between-gene heteroscedasti-
city; (3) there is only within-gene heteroscedasticity; and
(4) all error variances are identical. We now develop a
generalized shrinkage error estimator using these four
shrinkage targets.
Let Xi,k ≡ log ˆ σ2
i,k − m ∼ logσ2
i,k +l o gχ2
ν /ν − m,w h e r e
m is the mean of log logχ2
ν /ν. Then using asymptotic
normal approximation of Xi,k, the distribution of Xi,ks
with different shrinkage targets for different gene i and
group k combinations is
Xi,k|θi,k ∼ N
 
θi,k,σ2 
θi,k ∼ N
 
μ + αi + βk,τ2 
,
(1)
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Page 2 of 10where ˜ θ =
 
θ1,1,...,θ1,K,...,θI,1,...,θI,K
 
, ˜ α = (α1,...,αI)
represents the gene-specific mean differences, and
˜ β = (β1,...,βK) models different means with respect to
different classes of the subgroups.
If s
2 and τ
2 are known, then the Bayes estimator of θi,
k under the squared error loss is [39]:
θB
i,k =
σ2
σ2 + τ2 (μ + αi + βk) +
τ2
σ2 + τ2Xi,k.
Here, s
2 i st h ev a r i a n c eo fl o gχ2
ν /ν and is known
[28,40], but τ
2 is not known. However, the marginal dis-
tribution of Xi,k can be used to create an empirical
Bayes estimator of τ
2 and hence of θi,k.M a r g i n a l l y ,Xi,k
~ N(μ + ai + bk, s
2 + τ
2),i = 1,..., I, k = 1, ...K, and, from
this model, the least square estimates of μ, ˜ α, ˜ β, ˆ μ, ˜ α, ˆ β,
are the uniformly minimum-variance and unbiased esti-
mators. Using the fact that
E(
[IK − (I + K − 1) − 2]
 (Xi,k −ˆ μ −ˆ αi − ˆ βk)
2)=
1
σ2 + τ2,
the empirical Bayes estimator for τ
2 is
 (Xi,k −ˆ μ −ˆ αi − ˆ βk)2/[IK − (I + K − 1) − 2] − σ2.
Then, we can construct the positive-part empirical
Bayes estimator [40]:
θEB+
i,k = ˆ Xi,k +
 
1 −
[IK − (I + K − 1) − 2]σ2
 (Xi,k −ˆ μ −ˆ αi − ˆ βk)
2
 
+
ˆ Xi,k
ˆ Xi,k = ˆ μ + ˆ αi + ˆ βk,
where(x)+ = max(x, 0). The generalized shrinkage
error estimate for si,k can be obtained through exponen-
tiating θEB+
i,k as follows:
˜ σ2
Gen,i,k = exp(θEB+
i,k ). (2)
Using a similar argument, the generalized shrinkage
error estimator with the shrinkage target at each gene
is
˜ σ2
Gen−gene,i,k = exp(m + ˆ μ + ˆ αi)
∗exp[
 
1 −
[IK − (I − 1) − 2]σ2
 (Xi,k −ˆ μ −ˆ αi)
2
 
+
 
Xi,k −ˆ μ −ˆ αi
 
],
(3)
with the shrinkage target at each group is
˜ σ2
Gen−grp,i,k = exp(m + ˆ μ + ˆ βk)
∗exp[
 
1 −
[IK − (K − 1) − 2]σ2
 (Xi,k −ˆ μ − ˆ βk)
2
 
+
 
Xi,k −ˆ μ − ˆ βk
 
],
(4)
and with the shrinkage target at the common error,
we have
˜ σ2
Gen−ce,i,k = exp(m + ˆ μ)
∗exp[
 
1 −
[IK − 3]σ2
 (Xi,k −ˆ μ)
2
 
+
 
Xi,k −ˆ μ
 
].
(5)
The shrinkage error estimator proposed by Cui et al.
[28] shrinks the gene-specific error estimators toward
their common corrected geometric mean. Specifically,
the estimator for σ2
i is calculated as
˜ σ2
Cui,i = exp
 
m +
 Xi
I
 
∗exp[
⎛
⎜ ⎜
⎝1 −
[I − 3]σ2
 (Xi −
 Xi
I
)
2
⎞
⎟ ⎟
⎠
+
(Xi −
 Xi
I
)],
(6)
where Xi is the residual variance estimate from a
gene-specific model, and m and s
2 are the mean and
variance of log χ2Kν
Kν
. The underlying assumption for
this estimator is that there is no between-gene hetero-
scedasticity, as this estimator shrinks every gene-specific
error estimator toward one target. Therefore, it will
overshrink the gene-specific error estimates when gene
heteroscedasticity exists. In comparison, generalized
shrinkage error estimators are flexible in terms of incor-
porating a different type of heteroscedasticity. Some
degrees of freedom are used for incorporating the het-
eroscedasticity. However, the gain is that the error esti-
mator is then closer to the underlying distribution and
should lead to better performance of the resultant F-like
test statistics as shown in the results section.
In formulas (2), (3), (5), and (6), m is the mean and s
2
is the variance of a log-transformed chi-square random
variable. The simulation-based approximate values of m
and s
2 can be found from Table 1 in work of Cui et al.
[28]. Pounds [41] gave analytical expressions for these
parameters and developed R code for the exact calcula-
tion. Here, the simulation-based approximate values
were used.
Shrinkage F-like statistics
To construct a statistic for the hypothesis test of no
interaction between two fixed effects, the traditional F-
test is simply the ratio of the mean square of the inter-
action term (MSI) and the mean square of residuals
(MSE). This F-test, referred to as F1 [42], is
F1 =
MSI
MSE
=
MSI
ˆ σ2 .T h eF1 test corresponding to a speci-
fic gene i is denoted by
F1,i =
MSIi
ˆ σ2
i
. (7)
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from only gene i. In oligonucleotide mi-croarray models,
the degrees of freedom for the error estimate can be
small because the sample size of RNA is usually small,
and hence the power of F1 can be limited.
Following the method of constructing an F-test statis-
tic given by Neter et al. [42], the gene-specific shrinkage
F-like statistics for testing an interaction between two
fixed effects can be obtained as
FGen,i =
MSIi
 k˜ σ2
Gen,i,k/K
,
FGen−gene,i =
MSIi
 k˜ σ2
Gen−gene,i,k/K
,
FGen−grp,i =
MSIi
 k˜ σ2
Gen−grp,i,k/K
,
FGen−ce,i =
MSIi
 k˜ σ2
Gen−ce,i,k/K
,
FCui,i =
MSIi
˜ σ2
Cui,i
.
When the homoscedastic error assumption is true, the
pooled variance estimator, ˆ σ2
pool, can be used to construct
an F-like statistic. For a balanced design, the pooled var-
iance estimate is the average of all gene-specific error
estimates. This statistic is denoted by F3 using the same
notation used by Cui and Churchill [22], who also intro-
duced another shrinkage-type F statistic, F2, which can
also borrow information across genes when estimating
the residual variances. The statistic F2 uses an equal-
weighted average of a gene-specific error estimator ˆ σ2
and ˆ σ2
pool. The definitions of F2,i and F3,i are
F2,i =
MSIi
0.5ˆ σ2
i +0 . 5ˆ σ2
pool
,
F3,i =
MSIi
ˆ σ2
pool
.
Permutation tests
For the proposed generalized shrinkage F-like test statis-
tics, the null distributions are not known named distri-
butions. Therefore, an empirical approach such as a
permutation test can be used to estimate the null distri-
butions. The permutation test for interaction is compli-
cated, because there is no exact permutation test for
such a purpose [43]. We therefore must consider an
approximate permutation method for testing an interac-
tion term in a crossed fixed/mixed model [44,45].
Permutation approaches developed previously focused
on a single ANOVA model. In the typical gene expres-
sion study, thousands of ANOVA models are considered
simultaneously. The additional complexity of the shrink-
age F-like statistics indicates that Monte Carlo studies
are needed to investigate the performance of residual
permutation and raw data permutation, with restrictions
or not, in a gene-expression analysis. The choice of per-
mutation procedures is critical for assessing the perfor-
mance of a test statistic.
For all the modified F-like statistics presented in the
previous section, the null distributions can only be
approximated empirically, but permutation procedures
can be used to find the approximate null distribution of
all the F and F-like statistics. The important issues in
performing a permutation analysis include the choice of
the exchangeable units under the null hypothesis, the
choice of using restricted permutation or not, and the
choice of residual permutation or raw data permutation.
These choices influence the power of a test statistic.
Residual permutation using residuals from a reduced
model and unrestricted raw data permutation can be
used to approximate the null distribution of a statistic
for testing an interaction term [44]. When using F1 to
test an interaction term in a single ANOVA model, the
residual permutation leads to a more powerful test than
unrestricted raw data permutation [44]. However, in
gene expression analysis, thousands of gene-specific
ANOVA models are simultaneously considered, and for
Table 1 Results from raw data permutation
Restricted? Data set F1 F2 F3 FCui FGen FGen-gene FGen-grp
YES null-ce 5.05(0.07) 5.06(0.08) 5.12(0.17) 5.09(0.10) 5.09(0.10) 5.05(0.08) 5.11(0.10)
null-gh 5.02(0.07) 5.13(0.16) 5.26(0.20) 5.03(0.07) 5.07(0.12) 5.03(0.07) 5.11(0.16)
null-wgh 4.97(0.07) 4.96(0.09) 4.93(0.18) 4.99(0.08) 4.99(0.12) 4.96(0.09) 5.01(0.16)
null-bgh 5.02(0.07) 4.99(0.17) 5.03(0.21) 5.02(0.07) 5.02(0.15) 5.01(0.09) 5.03(0.18)
NO null-ce 5.10(0.07) 5.06(0.08) 5.06(0.08) 7.4(0.12) 5.15(0.09) 5.12(0.08) 5.08(0.08)
null-gh 5.08(0.07) 5.12(0.16) 5.12(0.12) 7.4(0.09) 5.10(0.11) 5.07(0.10) 5.12(0.09)
null-wgh 12.31(0.10) 7.56(0.10) 4.61(0.10) 17.37(0.14) 5.32(0.11) 5.07(0.09) 5.87(0.11)
null-bgh 12.31(0.11) 6.63(0.17) 5.55(0.19) 15.68(0.12) 6.30(0.12) 6.10(0.11) 6.30(0.11)
CWER obtained from 1,000 permutations with the nominal significance level setting at 0.05, with standard errors in parentheses. Nine hundred simulation runs
were performed to get empirical average CWER of all types of F-like test statistics.
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from other gene-specific ANOVA models is used to
construct the shrinkage error estimate. Hence, both resi-
dual permutation and raw data permutation were inves-
tigated. Furthermore, both restricted and unrestricted
permutations were studied, because the permutation
units are exchangeable only within each particular
group when within-gene heteroscedasticity is present
across those subgroups.
Results
The properties of this shrinkage estimator are compared
with those of other existing F and F-like statistics that
have been proposed and described in the “Shrinkage F-
like statistics” section.
Simulation studies
The purpose of these simulation studies was to compare
the performances of F1, F2, F3, FCui, FGen, FGen-gene,a n d
FGen-grp in terms of type I error and power and to com-
pare the results of a particular F-like statistic using four
different permutation strategies: restricted/unrestricted
residual permutation and restricted/unrestricted raw
data permutation.
In these simulation studies, 100 genes with two probes
for each gene and three replicates from each of two
lines were simulated to mimic a split-plot design in a
general oligonu-cleotide microarray experiment. The
gene-specific ANOVA model in which data were gener-
ated from the model, yplr = Pp + Ll + RLrl + PLpl + plr,
wp =1 ,2 ,l =1 , 2 ,r = 1,2,3, where P, L, RL,a n dPL
represent probe, line, replicates from a particular line,
and the interaction between probe and line, respectively.
Replicates were nested within each line, and RL is
usually treated as a random effect during the model-fit-
ting procedure, which results in a correlation between
probes from the same biological sample. In the simu-
lated data sets, the correlation between genes was 0. As
many as 900 simulation runs were carried out to com-
pare the performances of F1, F2, F3, FCui, FGen, FGen-gene,
and FGen-grp based on different permutation procedures.
The four permutations tested were unrestricted residual
permutation, restricted residual permutation with
respect to each line, unrestricted raw data permutation,
and restricted raw data permutation with respect to
each line. The residuals permuted were from a reduced
fixed model with fixed effects for only line and probe.
Two types of data were simulated: null cases and cases
with a probe by line interaction at a range of degrees.
Null cases included: null-ce, all probe-level expression
values were simulated from the standard normal distri-
bution; null-gh, the gene-specific error variances were
simulated from the log-normal distribution with mean
log at 0 and standard deviation at 2, mimicking the
general heteroscedastic error distribution in typical data-
sets; null-wgh, all genes had the same error structures
and the residual error variance of line 1 was 100 times
that of line 2; null-bgh, simulated data were modified
from null-gh, with the variance of line 1 multiplied by
100. Correspondingly, ce, gh, wgh,a n dbgh in Figures 1
and 2 were simulated by adding interaction terms to
null-ce, null-gh, null-wgh,a n dnull-bgh. Quantitative
interaction was assumed and the differences in the
opposite direction were set to make the detection
powers for an interaction term based on traditional F-
statistics and tabled p-values range from 0.05 to 0.95.
Tables 1 and 2 show the results from 900 simulation
runs using raw data permutation and residual permuta-
tion, respectively. Data in Table 1 suggest that when
both types of gene heteroscedasticity exist, the unrest-
ricted raw data permutation had a greater average com-
parison-wise error rate (CWER) than residual
permutation. Raw data permutation with restriction can
control prespecified CWER im all cases. In Table 2, for
the common error cases, all test statistics had the pre-
specified CWER from both restricted and unrestricted
residual permutation. When within-gene heteroscedasti-
city existed, F1 and FCui h a di n f l a t e dC W E Rf r o mb o t h
two residual permutation tests. Restricted residual per-
mutation reduces, but does not solve, this problem. For
F2 and F3, only the restricted residual permutation could
control the prespecified CWER. For FGen, FGen-gene,a n d
FGen-grp, restricted residual permutation gave conserva-
tive results in terms of having CWER smaller than the
prespecified level. When the shrinkage target is correctly
set, unrestricted residual permutation controls the nom-
inal CWER. As expected, only FGen coupled with unrest-
ricted residual permutation could be used for all cases,
because the CWER was always less than the nominal
level.
Further simulations to compare the rejection rates
were conducted. Only results from residual permutation
are shown because it was found that raw data permuta-
tion was less powerful than residual permutation. This
is consistent with the findings of Anderson and Ter
Braak [44]. Figure 1 shows the estimated average null
hypothesis rejection rate curves from all F-like statistics
and both restricted and unrestricted residual permuta-
tion procedures. The x-axis represents the average null
hypothesis rejection rate using F1 and the tabulated p-
values. The solid line shows that the corresponding sta-
tistic controls the prespecified CWER, and the dashed
line shows that the corresponding CWER was inflated.
In general, restricted residual permutation is less power-
ful than unrestricted residual permutation. For example,
the power of all statistics from unrestricted residual per-
mutation almost doubled in some cases where hetero-
scedasticity existed.
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obviously the most powerful test and the prespecified
CWER is controlled. All other F-like statistics performed
very similarly in this case. When the shrinkage target
was correctly set, the resultant test statistic was the
most powerful one. For example, when there was only
within-gene heteroscedasticity, FGen-grp was more power-
ful than FGen and FGen-gene based on either restricted or
unrestricted residual permutation. The rejection rate
comparison of statistically valid test statistics is further
illustrated in Figure 2, where the x-axis is the average
rejection rate from using FGen and unrestricted residual
permutation. Figure 2 clearly shows that unrestricted
residual permutation is more favorable in terms of
power. FGen-grp appears to be more powerful than FGen,
but when both types of gene heteroscedasticities occur,
FGen grp has inflated CWER.
Drosophila data
T h ed a t au s e di nt h i ss t u d ya r ef r o mag e n ee x p r e s s i o n
comparison study between D. melanogaster and D. simu-
lans [46]. Expression of 10 genotypes of each species was
measured in male flies. In D. simulans, each genotype was
measured separately, and in D. melanogaster, a pool of 10
genotypes was measured. All genotypes (individual or
pooled) were independently isolated and hybridized three
times. The goal of the original study was to provide a gen-
ome-wide approach to identifying candidate genes poten-
tially responsible for adaptation and speciation in D.
simulans and D. melanogaster. In this study, we focus on
Figure 1 The comparison of power curves of all F-like test statistics. The x-axis is the average power from analyzing 900 simulated data
sets using F1 with tabled p-values. The y-axis is the estimated powers using empirical gene-specific null distributions from 1,000 residual
permutations. The upper four plots show the results with restricted residual permutation, while the lower four plots show the results from
unrestricted residual permutation. The solid line indicates the empirical average CWER of a statistic is at the prespecified level, and the dashed
line shows an inflated empirical average CWER."ce,” all genes have common error; “gh,” only between-gene heteroscedasticity exists; “wgh,” only
within-gene heteroscedasticity exists; “bgh,” both between-gene and within-gene heteroscedasticity exist.
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Page 6 of 10identifying sequence differences between genotypes in D.
simulans based on hybridization profiles. Within-gene het-
eroscedasticity is expected because the genotypes come
from different lines. The proposed generalized shrinkage
F-like test statistics FGen, FGen-gene, and FGen-grp were com-
pared with F2, F3 with restricted residual permutation,
which could control prespecified CWER for any variance
structure in simulation studies. Furthermore, Smyth’s
moderated F-test statistic [25] without multiple testing
adjustment and controlling the false discovery rate (FDR)
at 5% were used for comparison. As the main interest is in
sequence difference, the focus is on the test of interaction
between line and probe. The split plot model described
above is used. SAS program codes are included in the
additional files (additional file 1 and additional file 2).
The Drosophila genome has been fully sequenced and
both SNPs and indels can cause a significant interaction
term. Thus, the false positive rate and detection power
Figure 2 The comparison of power curves of FGen from unrestricted residual permutation versus other F-like test statistics. Only results
from permutation combinations that can control prespecified CWER are used in this figure. The x-axis is the average power after analyzing 900
simulated data sets using FGen and 1,000 unrestricted residual permutations. The y-axis is the estimated power from other F-like test statistics and
empirical gene-specific null distributions based on the appropriate permutation. The solid black line corresponds to FGen with unrestricted
permutation, and this test always controls prespecified CWER."ce,” all genes have common error; “gh,” only between-gene heteroscedasticity
exists; “wgh,” only within-gene heteroscedasticity exists; “bgh,” both between-gene and within gene heteroscedasticity exist; “res,” restricted
permutation; “unres,” unrestricted permuation.
Table 2 Results from residual permutation
Restricted? Data set F1 F2 F3 FCui FGen FGen-gene FGen-grp
YES null-ce 4.59(0.07) 4.15(0.08) 3.63(0.14) 4.09(0.09) 4.55(0.07) 3.23(0.06) 4.44(0.08)
null-gh 4.57(0.07) 4.1(0.13) 3.95(0.16) 4.49(0.07) 4.6(0.07) 4.61(0.07) 4.38(0.07)
null-wgh 6.74(0.08) 4.33(0.08) 3.51(0.14) 6.49(0.09) 4.38(0.07) 4.2(0.07) 2.78(0.09)
null-bgh 6.74(0.08) 4.35(0.16) 4.07(0.19) 6.58(0.08) 4.36(0.07) 4.16(0.07) 3.64(0.07)
NO null-ce 5.1(0.07) 4.99(0.08) 4.5(0.08) 4.59(0.08) 4.99(0.07) 4.1(0.07) 4.68(0.07)
null-gh 5.1(0.07) 4.83(0.1) 4.59(0.11) 5.08(0.07) 4.99(0.07) 5.01(0.07) 4.95(0.07)
null-wgh 10.75(0.09) 8.46(0.09) 7.6(0.09) 12.37(0.11) 5.03(0.08) 6.43(0.08) 4.93(0.08)
null-bgh 10.75(0.1) 8.38(0.17) 8.07(0.19) 10.79(0.1) 5.02(0.08) 6.38(0.08) 6.73(0.08)
CWER obtained from 1,000 permutations with the nominal significance level setting at 0.05, with standard errors in parentheses. Nine hundred simulation runs
were performed to get empirical average CWER of all types of F-like test statistics.
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lated for a subset of the data. In the data set, there were
10 lines from D. simulans and three replicates from
each line. Each probe set had 14 probes. The 1,285 pro-
besets containing all “good” probes were selected. A
“bad” probe’s sequence satisfies one or more of the fol-
lowing criteria: it matches the D. simulans genome mul-
tiple times; it cannot be mapped to the flybase 4.2.1
genome; or, it has no information, such as hitting out-
side an exon, hitting a poorly aligned region, or hitting a
region lacking a sequence. SNP or indel information
could be determined in 777 probesets. For this data set,
there was a high degree of within-gene heteroscedasti-
city: about 22.3% of the probe sets had a difference in
line-specific residual variance estimates as large as or
more than a 10-fold change. Therefore, as suggested by
the conclusions from simulation studies, unrestricted
residual permutation and restricted residual permutation
were used for generalized shrinkage F-like test statistics
(FGen, FGen-gene, FGen-grp) and restricted residual permuta-
tion was used for statistics (F2, F3). The results are
shown in Table 3. Consistent with the findings from the
simulation studies, FGen had about 30% more detecting
power by valuing the within-gene heteroscedasticity
than the other F-like test statistics (F2, F3). The false dis-
covery rate of FGen was slightly higher than that of F2,
F3. FGen-gene and FGen-grp performed similarly to FGen.
Both of Smyth’s moderated F-test statistic without mul-
tiple testing adjustment and with FDR set at 5% for
multiple testing adjustment detected more SNPs and
indels but at the expense of a greater FDR than FGen.
Discussion
For gene expression analysis, ANOVA models have been
a popular modeling technique. Based on ANOVA mod-
els, flexible shrinkage F-like test statistics were devel-
oped to account for both the within-gene and between-
gene heteroscedasticities. The emphasis here is on
testing an interaction term, as this case is of increasing
interest to biologists, and there is no clear existing the-
ory on the most powerful, valid approach for such sta-
tistics. For all F-like statistics studied here, their null
distributions were approximated empirically through
permutations. Four different permutation procedures
were investigated for eight different F-like statistical
tests of the interaction term.
As expected, we found that when an error estimator
overshrinks, the resulting F-like statistic cannot control
the prespecified CWER. For example, FGen-gene is an
over-shrinkage error estimator when there is within-
gene heteroscedasticity. As a result, compared with gen-
eralized shrinkage F-like statistics, it is not valid when
within-gene heteroscedasticity exists. Undershrinkage is
also important, as it will lead to a conservative test and
lower power. This is clearly demonstrated when the
common error can be assumed and the most powerful
valid test is FGen-grp.
The most striking result was the impact of the per-
mutation procedures. Although this was not comple-
tely unexpected [43-45], the effect of the permutation
procedures is dramatic and worthy of special attention.
Unrestricted raw data permutation could not control
prespeci-fied CWER when there was within-gene het-
eroscedasticity. Restricted raw data permutation could
be used, but it was less powerful than residual permu-
tation. Also consistent with findings from Anderson
and Ter Braak [44], restricted permutations are less
powerful than unrestricted permutations. However,
unrestricted permutations are valid only for a common
error and when between-gene heteroscedasticity exists
for our proposed shrinkage statistics; they are not valid
in combination with F2, F3,o rFCui. For FGen-grp,t h e
unrestricted permutation can also be used in cases
having within-gene heteroscedasticity, while only FGen
is valid with unrestricted permutation in all cases in
terms of controlling prespecified CWER. Interestingly,
Table 3 Probe sets with significant line*probe terms found by F-like test statistics and appropriate residual
permutation procedures and Smyth’s moderated F-test statistic
Test statistic Restricted permutation? Number of probe sets found True false discovery rate Power
F2 Yes 124 22.6% 12.4%
F3 Yes 187 29.4% 17.1%
FGen No 453 29.5% 41.1%
FGen-gene No 455 28.8% 41.7%
FGen-grp No 474 28.9% 43.4%
FGen Yes 136 24.3% 13.3%
FGen-gene Yes 122 22.1% 12.2%
FGen grp Yes 116 21.5% 11.7%
moderatedF - 1 N/A 535 34.1% 75.5%
moderatedF - 2 N/A 813 34.4% 68.8%
The CWER was set to 0.05. Gene-specific cutoff values were obtained from 1,000 permutations. “moderated F-1” and “moderated F-2” represent results from
using moderated F statistic without any multiple testing adjustment and setting FDR to 5%.
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Page 8 of 10the power gain from using the correct shrinkage target
FGen-grp rather than FGen is far less than that of using
unrestricted permutation. The result is that F3 is never
the most powerful choice when testing an interaction
term.
The correct shrinkage target can lead to the most
powerful test statistic. As one of the reviewers sug-
gested, a statistical test may be applied to help pick the
best shrinkage target before obtaining shrinkage error
estimates. However, this extra testing step may inflate
the CWER of the test statistic when there is gene het-
eroscedasticity. For example, when there are both types
of gene heteroscedasticities, it is possible that the above
test suggests only within-gene heteroscedasticities exist,
and FGen-grp is shown to inflate the CWER. There is
minimal penalty to using the shrinkage estimator we
propose, so we recommend setting the shrinkage target
in the full space spanned by group and gene and using
unrestricted permutation to compensate for the possible
power loss in fewer degrees of freedom left for estimat-
ing the errors.
Conclusions
The proposed generalized shrinkage F-like statistic with
shrinkage targets located in a space spanned by gene
and another group, FGen, with unrestricted residual per-
mutation is always valid in terms of having a prespeci-
fied CWER. This statistic has reasonable power in most
cases; thus, it is generally recommended to be applied to
test an interaction term in the analysis of real gene
expression data.
Additional material
Additional file 1: SAS program code 1. SAS program code for
analyzing the real data set using residual permutation without restriction.
Additional file 2: SAS program code 2. SAS program code for
analyzing the real data set using residual permutation with restriction.
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